Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
Published on: July 14, 2023
Multiplex Detection of Three Select Agents Directly from Blood by Use of the GeneXpert System
Padmapriya P Banada1, Srinidhi Deshpande2, Sukalyani Banik2
1Center for Emerging Pathogens, Division of Infectious Diseases, New Jersey Medical School, Rutgers Biomedical and Health Sciences University, Newark, New Jersey, USA Priya.banada@rutgers.edu allandda@njms.rutgers.edu.
Abstract:
Francisella tularensis, Bacillus anthracis, and Yersinia pestis are tier 1 select agents with the potential to rapidly cause severe disease. Rapid detection of these bacteria from patient samples at the point of care could contribute to improved clinical outcomes in the event of a bioterrorism attack. A multiplex nested PCR assay for detection of F. tularensis, B. anthracis, and Y. pestis directly from patient blood samples was developed using the GeneXpert system. The multiplex GeneXpert cartridge-based assay includes all necessary sample processing and amplification reagents. Blood samples spiked with different numbers of CFU were used to measure the analytical limit of detection (LOD) and dynamic range. Sensitivity was determined by testing spiked blood samples and negative-control blood in a blind manner. Specificity was determined by testing against nontarget pathogens and blood samples from clinical patients. The assay LOD was 8.5 CFU/ml for F. tularensis, 10 CFU/ml for B. anthracis, and 4.5 CFU/ml for Y. pestis The sensitivity was 100% at the LOD for all three select agent bacteria in spiked patient blood samples. The assay specificity was 100% when it was tested against both nontarget pathogens and clinical patient blood samples. The total assay time was approximately 100 min. This automated assay, which is suitable for use at the point of care, identifies three select agents directly in blood without the need for enrichment with a high sensitivity within 100 min. This assay may enable rapid detection and treatment of patients infected with the target organisms in the event of a bioterrorism attack.
Insights
A new GeneXpert assay rapidly detects three dangerous bacteria: Francisella tularensis, Bacillus anthracis, and Yersinia pestis. This point-of-care test offers high sensitivity and specificity in blood samples within 100 minutes.
Area of Science:
- Microbiology and Infectious Diseases
- Biotechnology and Molecular Diagnostics
- Public Health and Biodefense
Background:
- Tier 1 select agents like *Francisella tularensis*, *Bacillus anthracis*, and *Yersinia pestis* pose significant bioterrorism threats.
- Timely detection of these pathogens is crucial for effective patient management and public health response.
- Current diagnostic methods may lack the speed and point-of-care suitability required for bioterrorism scenarios.
Purpose of the Study:
- To develop and validate a rapid, multiplex, cartridge-based assay for the simultaneous detection of *F. tularensis*, *B. anthracis*, and *Y. pestis*.
- To assess the assay's analytical performance, including limit of detection (LOD), sensitivity, and specificity, directly from patient blood samples.
- To evaluate the suitability of the assay for point-of-care use in bioterrorism preparedness.
Main Methods:
- Development of a multiplex nested PCR assay on the GeneXpert system.
- Determination of analytical limit of detection (LOD) and dynamic range using spiked blood samples.
- Evaluation of assay sensitivity and specificity using spiked blood, negative controls, and clinical samples.
Main Results:
- The assay achieved limits of detection of 8.5 CFU/ml for *F. tularensis*, 10 CFU/ml for *B. anthracis*, and 4.5 CFU/ml for *Y. pestis*.
- 100% sensitivity was observed at the LOD in spiked patient blood samples for all three target organisms.
- 100% specificity was confirmed against nontarget pathogens and clinical blood samples, with a total assay time of approximately 100 minutes.
Conclusions:
- The automated, cartridge-based GeneXpert assay enables rapid, sensitive, and specific detection of three critical select agent bacteria directly from blood.
- This point-of-care assay provides results within 100 minutes without the need for sample enrichment.
- The developed assay holds significant potential for timely diagnosis and treatment initiation in bioterrorism events.
Related Concept Videos
What is Natural Selection?
Subviral Agents
Antibiotic Selection
Types of Selection
Air-entraining Agents
Frequency-dependent Selection

